Consonance Capital Management LP Has Increased Spectrum Pharmaceuticals (SPPI) Position; Rsp Permian (RSPP) Holder Lombard Odier Asset Management Usa Has Decreased Holding by $408,000

January 13, 2018 - By Michael Collier

Lombard Odier Asset Management Usa Corp decreased its stake in Rsp Permian Inc (RSPP) by 5.66% based on its latest 2017Q3 regulatory filing with the SEC. Lombard Odier Asset Management Usa Corp sold 12,000 shares as the company’s stock declined 5.27% while stock markets rallied. The institutional investor held 199,849 shares of the energy company at the end of 2017Q3, valued at $6.91M, down from 211,849 at the end of the previous reported quarter. Lombard Odier Asset Management Usa Corp who had been investing in Rsp Permian Inc for a number of months, seems to be less bullish one the $6.68 billion market cap company. The stock increased 0.17% or $0.07 during the last trading session, reaching $42.09. About 1.28 million shares traded. RSP Permian, Inc. (NYSE:RSPP) has risen 25.82% since January 13, 2017 and is uptrending. It has outperformed by 9.12% the S&P500.

Mitchell Blutt increased its stake in Spectrum Pharmaceuticals Inc (SPPI) by 331.02% based on its latest 2017Q3 regulatory filing with the SEC. Consonance Capital Management Lp bought 6.69M shares as the company’s stock declined 2.71% while stock markets rallied. The hedge fund run by Mitchell Blutt held 8.71 million shares of the health care company at the end of 2017Q3, valued at $122.54M, up from 2.02 million at the end of the previous reported quarter. Consonance Capital Management Lp who had been investing in Spectrum Pharmaceuticals Inc for a number of months, seems to be bullish on the $1.94 billion market cap company. The stock increased 0.62% or $0.12 during the last trading session, reaching $19.42. About 557,601 shares traded. Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) has declined 20.03% since January 13, 2017 and is downtrending. It has underperformed by 36.73% the S&P500.

Among 6 analysts covering Spectrum Pharma (NASDAQ:SPPI), 6 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Spectrum Pharma had 11 analyst reports since August 7, 2015 according to SRatingsIntel. As per Monday, October 9, the company rating was maintained by Jefferies. Jefferies maintained it with “Buy” rating and $900 target in Wednesday, June 7 report. The firm has “Buy” rating by Jefferies given on Friday, February 10. The stock has “Outperform” rating by RBC Capital Markets on Friday, August 7. On Thursday, November 5 the stock rating was maintained by RBC Capital Markets with “Outperform”. H.C. Wainwright reinitiated it with “Buy” rating and $14 target in Wednesday, August 16 report. The company was upgraded on Thursday, August 27 by Zacks. Jefferies maintained Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) rating on Thursday, August 24. Jefferies has “Buy” rating and $9.0 target.

Investors sentiment increased to 2.84 in Q3 2017. Its up 1.89, from 0.95 in 2017Q2. It improved, as 13 investors sold SPPI shares while 19 reduced holdings. 38 funds opened positions while 53 raised stakes. 71.60 million shares or 29.39% more from 55.33 million shares in 2017Q2 were reported. Grantham Mayo Van Otterloo And Communications Lc holds 0% or 15,300 shares in its portfolio. Parametric Portfolio Associates Ltd Liability Corporation stated it has 0% in Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI). Amalgamated Natl Bank has invested 0% of its portfolio in Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI). Morgan Stanley stated it has 328,504 shares. Principal Fin invested in 0.01% or 586,141 shares. Ohio-based Meeder Asset Mgmt has invested 0% in Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI). Riverhead Capital Limited Liability Com invested in 3,773 shares. Bankshares Of New York Mellon owns 0% invested in Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) for 919,334 shares. Cambridge Investment Advsr has 0.01% invested in Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI). Barrow Hanley Mewhinney Strauss Ltd Co reported 231,745 shares or 0% of all its holdings. State Of Wisconsin Investment Board invested 0% of its portfolio in Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI). Focused Wealth Mngmt Inc has invested 0.02% in Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI). Blackrock stated it has 11.98M shares or 0.01% of all its holdings. Ls Inv Advisors holds 3,217 shares. Alliancebernstein Limited Partnership holds 0% in Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) or 83,175 shares.

Consonance Capital Management Lp, which manages about $513.80 million and $904.16M US Long portfolio, decreased its stake in Amarin Corp Plc (NASDAQ:AMRN) by 175,000 shares to 24.65 million shares, valued at $86.27M in 2017Q3, according to the filing. It also reduced its holding in La Jolla Pharmaceutical Co (NASDAQ:LJPC) by 10,000 shares in the quarter, leaving it with 2.00 million shares, and cut its stake in Myriad Genetics Inc (NASDAQ:MYGN).

Investors sentiment decreased to 1.28 in Q3 2017. Its down 0.39, from 1.67 in 2017Q2. It worsened, as 35 investors sold RSPP shares while 59 reduced holdings. 36 funds opened positions while 84 raised stakes. 133.37 million shares or 0.04% less from 133.41 million shares in 2017Q2 were reported. Adams Natural Resource Fund accumulated 145,000 shares. Wexford Capital LP owns 639,859 shares for 1.9% of their portfolio. Eagle Asset Management Inc stated it has 3.84M shares or 0.77% of all its holdings. National Bank & Trust Of Montreal Can invested in 134,347 shares. Fmr Ltd Liability Company holds 0.02% or 5.84 million shares. Teachers & Annuity Association Of America holds 5.01 million shares or 4.68% of its portfolio. Bbt Capital Mgmt holds 0.16% of its portfolio in RSP Permian, Inc. (NYSE:RSPP) for 31,900 shares. At Bankshares holds 0.08% of its portfolio in RSP Permian, Inc. (NYSE:RSPP) for 19,443 shares. 23,061 were reported by Wesbanco Bancorporation. Northern Tru Corporation invested in 0.01% or 1.05 million shares. Art Ltd Liability, a New York-based fund reported 11,600 shares. Parametric Assocs Limited Liability Corp owns 215,829 shares. Amalgamated Fincl Bank holds 0.03% or 24,285 shares in its portfolio. Fiera Cap stated it has 0.09% of its portfolio in RSP Permian, Inc. (NYSE:RSPP). Tiaa Cref Invest Mgmt Limited Liability Company accumulated 5.10 million shares.

Since August 9, 2017, it had 0 insider purchases, and 7 selling transactions for $8.66 million activity. 47,113 shares were sold by Arrott Zane W., worth $1.47M. Mutrie James E. sold 12,447 shares worth $391,707. McNeill Scott K. sold 25,000 shares worth $926,250.

Lombard Odier Asset Management Usa Corp, which manages about $3.79B and $1.41B US Long portfolio, upped its stake in Tenet Healthcare Corp (Put) (NYSE:THC) by 23,000 shares to 43,000 shares, valued at $706,000 in 2017Q3, according to the filing. It also increased its holding in Nabors Industries Ltd (NYSE:NBR) by 53,000 shares in the quarter, for a total of 153,000 shares, and has risen its stake in Commscope Hldg Co Inc (NASDAQ:COMM).

Analysts await RSP Permian, Inc. (NYSE:RSPP) to report earnings on February, 26. They expect $0.28 earnings per share, up 180.00% or $0.18 from last year’s $0.1 per share. RSPP’s profit will be $44.40 million for 37.58 P/E if the $0.28 EPS becomes a reality. After $0.18 actual earnings per share reported by RSP Permian, Inc. for the previous quarter, Wall Street now forecasts 55.56% EPS growth.

Among 35 analysts covering RSP Permian (NYSE:RSPP), 33 have Buy rating, 0 Sell and 2 Hold. Therefore 94% are positive. RSP Permian had 121 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Outperform” rating by RBC Capital Markets given on Wednesday, November 4. The stock of RSP Permian, Inc. (NYSE:RSPP) has “Buy” rating given on Monday, August 7 by RBC Capital Markets. Wunderlich maintained the stock with “Buy” rating in Wednesday, November 4 report. The stock of RSP Permian, Inc. (NYSE:RSPP) earned “Buy” rating by Jefferies on Tuesday, October 3. The company was maintained on Wednesday, August 5 by Wunderlich. Morgan Stanley maintained it with “Overweight” rating and $46 target in Wednesday, October 18 report. The company was initiated on Wednesday, June 15 by Imperial Capital. FBR Capital maintained it with “Outperform” rating and $44 target in Thursday, May 4 report. RBC Capital Markets maintained RSP Permian, Inc. (NYSE:RSPP) on Monday, May 15 with “Buy” rating. The stock of RSP Permian, Inc. (NYSE:RSPP) has “Neutral” rating given on Wednesday, August 5 by TH Capital.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: